Effects of high-dose medroxyprogesterone given for endometrial carcinoma on serum proteins.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001798:Blood Proteins / Q000378:metabolism*; D003864:Depression, Chemical; D005260:Female; D006023:Glycoproteins / Q000097:blood; D006242:Haptoglobins / Q000378:metabolism; D006801:Humans; D005779:Immunodiffusion; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D012709:Serum Albumin / Q000378:metabolism; D012712:Serum Globulins / Q000378:metabolism; D013268:Stimulation, Chemical; D013997:Time Factors; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy*
D001798:Blood Proteins; D006023:Glycoproteins; D006242:Haptoglobins; D012709:Serum Albumin; D012712:Serum Globulins; D008525:Medroxyprogesterone